ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...
Optometrist Amy Green discussed the importance of OCT in identifying AMD cases during the AOP’s Locum Clinical Skills ...
A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...
Two researchers from DTU are among this year's recipients of the Lundbeck Foundation's Ascending Investigator grants, which ...
By reducing inflammation, the researchers were able to prevent both the buildup of immune cells and the formation of these ...
Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...
2don MSN
Reducing inflammation may protect against early age-related macular degeneration-like vision loss
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...
Older age in adults with diabetic macular edema (DME) appears to be associated with less robust visual and anatomic gains from anti-vascular endothelial growth factor (VEGF) therapy, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback